Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,901 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic and immune profiling of pre-invasive lung adenocarcinoma.
Chen H, Carrot-Zhang J, Zhao Y, Hu H, Freeman SS, Yu S, Ha G, Taylor AM, Berger AC, Westlake L, Zheng Y, Zhang J, Ramachandran A, Zheng Q, Pan Y, Zheng D, Zheng S, Cheng C, Kuang M, Zhou X, Zhang Y, Li H, Ye T, Ma Y, Gao Z, Tao X, Han H, Shang J, Yu Y, Bao D, Huang Y, Li X, Zhang Y, Xiang J, Sun Y, Li Y, Cherniack AD, Campbell JD, Shi L, Meyerson M. Chen H, et al. Among authors: zheng s, zheng q, zheng d, zheng y. Nat Commun. 2019 Nov 29;10(1):5472. doi: 10.1038/s41467-019-13460-3. Nat Commun. 2019. PMID: 31784532 Free PMC article.
Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma.
Zhao Y, Shang J, Gao J, Han H, Gao Z, Yan Y, Zheng Q, Ye T, Fu F, Deng C, Ma Z, Zhang Y, Zheng D, Zheng S, Li Y, Cao Z, Shi L, Chen H. Zhao Y, et al. Among authors: zheng s, zheng q, zheng d. Front Immunol. 2022 Jul 1;13:921761. doi: 10.3389/fimmu.2022.921761. eCollection 2022. Front Immunol. 2022. PMID: 35844495 Free PMC article.
Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy.
Zhang Y, Deng C, Ma X, Gao Z, Wang S, Zheng Q, Xia G, Wen Z, Han H, Fu F, Liu Q, Hu H, Li Y, Wong KK, Chen H. Zhang Y, et al. Among authors: zheng q. J Cancer Res Clin Oncol. 2020 Sep;146(9):2411-2417. doi: 10.1007/s00432-020-03234-6. Epub 2020 Apr 30. J Cancer Res Clin Oncol. 2020. PMID: 32356178
A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.
Yuan C, Chen H, Tu S, Huang HY, Pan Y, Gui X, Kuang M, Shen X, Zheng Q, Zhang Y, Cheng C, Hong H, Tao X, Peng Y, Yao X, Meng F, Ji H, Shao Z, Sun Y. Yuan C, et al. Among authors: zheng q. Genome Biol. 2021 May 17;22(1):156. doi: 10.1186/s13059-021-02376-1. Genome Biol. 2021. PMID: 34001209 Free PMC article.
7,901 results